19:50 EDT Zyversa Therapeutics Inc trading halted, news pending
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZVSA:
- ZyVersa Therapeutics Approves Reverse Stock Split
- ZyVersa Therapeutics Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions in Patients with Diabetes
- ZyVersa Therapeutics highlights publication on NLRP3 inflammasome inhibition
- Zyversa Therapeutics’ 1-for-35 Reverse Split: Navigating the Risks to Shareholder Value and Liquidity
- ZyVersa Therapeutics expects cas to fund requirements on month-to-month basis